Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud's phenomenon and systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 17, Issue 1, 1999, Pages 49-54

  Anderson, M E ^a   Campbell, F ^b   Hollis, S ^c   Moore, T ^a   Jayson, M I V ^a   Herrick, A L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Iontophoresis; Laser Doppler; Primary Raynaud's phenomenon; Scleroderma; Systemic sclerosis; Vascular responses

Indexed keywords

ACETYLCHOLINE; ADRENALIN; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCLERODERMA; SYSTEMIC SCLEROSIS;

ACETYLCHOLINE; ADOLESCENT; ADULT; BLOOD FLOW VELOCITY; EPINEPHRINE; FEMALE; FINGERS; HUMANS; IONTOPHORESIS; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; NITROPRUSSIDE; PILOT PROJECTS; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; VASODILATOR AGENTS;

EID: 0032984013     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. KAHALEH B, MATUCCl-CERINIC M: Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone. Arthritis Rheum 1995; 38: 1-4.
2. ANDERSON ME, HOLLIS S, MOORE T, JAYSON MIV, HERRICK AL: Non-invasive assessment of vascular reactivity in forearm skin of patients with primary Raynaud's phenomenon and systemic sclerosis. Br J Rheumatol 1996; 35: 1281-8.
3. KASSAN DG, LYNCH AM, STILLER MJ: Physical enhancement of dermatologie drug delivery: Iontophoresis and phonophoresis. J Am Acad Dermatol 1996; 34: 657-66.
4. PRESCOTT RJ, FREEMONT AJ, JONES CJP, HOYLAND J, FIELDING P: Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 1992; 166: 255-63.
5. MATUCCI-CERINIC M, PlETRINI U, MARABINI S: Local venomotor response to intravenous infusion of substance P and glyceryl trinitrate in systemic sclerosis. Clin Exp Rheumatol 1990; 8: 561-5.
6. LEWIS T, LANDIS EM: Observations upon the vascular mechanism in acrocyanosis. Heart 1929; 15: 7-101.
7. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE ARA DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
8. KHAN F, LITCHFIELD SJ, MCLAREN M, VEALE DJ, LITTLEFORD RC, BELCH JJF: Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon. Arthritis Rheum 1997; 40: 352-7.
9. LA CIVITA, ROSSI M, VAGHEGGINI G et al.: Microvascular involvement in systemic sclerosis: Laser Doppler evaluation of reactivity to acetylcholine and sodium nitroprusside by iontophoresis. Ann Rheum Dis 1998; 57:52-5.
10. LlNDBIAD LE, EKERVALL L, ETZELL B, BEVEGARD S: Adrenoceptors in Raynaud's disease. J Cardiovasc Pharmacol 1989; 14: 881-5.
11. BURNSTOCK G: Integration of factors controlling vascular tone. Anesthesiology 1993; 79: 1368-80.